|
ATS/Alveolar Capillary Dysplasia (ACDMPV) Research Grant 1 grant available |
|
Target Audience: |
|
The focus of this research grant is proposals that advance research in the area of alveolar capillary dysplasia with misalignment of the pulmonary veins (ACDMPV). Proposals may be basic, translational, or clinical science research projects. Procedures or proposed therapeutic trials may be new, based on recent biochemical or pharmacological evidence, or in preliminary stages of clinical investigation. Evaluation of proposals will include careful consideration of protocol design, objectiveness of parameters measured, and statistical evaluation proposed. Protocols that will focus on treatment (rather than cause, early detection or diagnosis) will be given priority. |
|
ATS/Alpha-1 Foundation Research Grant |
|
1 grant available |
|
Target Audience: |
|
The focus of this research grant is proposals that have a high likelihood to advance the understanding of Alpha-1. Applications are encouraged from faculty members at any stage of their academic career. Applicants may request up to $40,000 per year for two years for salaries, supplies, or a combination of these two. Indirect costs will not be paid to the sponsoring institution. |
|
ATS/CSL Behring Research Award in Acute Respiratory Distress Syndrome (ARDS) |
| 1 grant available $50,000 per year for 1 year |
| Target Audience: Early-stage investigators interested in research on ARDS |
| The focus of this research grant is proposals that advance understanding of acute respiratory distress syndrome (ARDS). Applicants may request up to $50,000 for 1 year. Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or subject enrollment fees directly related to the project or other allowable costs. Travel for the PI for purposes of presenting data related to the project is limited to $2,000 per year. Indirect costs will not be paid to the sponsoring institution. |
|
ATS/Fisher & Paykel Healthcare Research Grant in Nasal High Flow |
| 1 grant available $50,000 per year for 2 years |
| Target Audience: Early-stage investigators interested in research on respiratory support with nasal high flow therapy in hospital patients |
| The focus of this research grant is proposals on respiratory support with nasal high flow therapy in hospital patients. Nasal high flow (NHF) therapy refers to a typical range from 20 to 70 L/min of heated, humidified gas delivered to the nares via purposely designed nasal cannula. Flow settings and fraction of delivered supplemental oxygen during the therapy vary depending on the patient’s level of compliance and severity of disease. There has been a recent rapid uptake in the use of NHF in acute care settings, primarily to treat hypoxemic respiratory failure, and the therapy has been extensively used around the world during the COVID-19 pandemic. Apart from efficient oxygenation due to the prevention of room air entrainment, NHF provides respiratory support that may be seen in the reduction of the breathing frequency and the work of breathing. Positive airway pressure and the reduction of re-breathing caused by the clearance of expired gas in the upper airways are believed to be the key mechanisms that may improve the ventilation efficiency during NHF. Saturation with water of heated gas maintains hydration of the airway surface liquid and preserves mucociliary function. |
|
ATS/Foundation for Sarcoidosis Research Grant 1 grant available |
| Target Audience: Early-stage investigators interested in research that is relevant to sarcoidosis |
|
The focus of this research grant is proposals that advance research in the area of sarcoidosis. Applicants may request up to $25,000 per year for two years. Granted funds may be used to provide salary support for the PI or ancillary staff, to purchase supplies and/or reagents, or for subject enrollment fees directly related to the project or other allowable costs. Indirect costs will not be paid to the sponsoring institution. |
Deadlines:
